These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4027025)

  • 21. Medical treatment of gallstones: ursodeoxycholic acid.
    Drug Ther Bull; 1984 Feb; 22(4):13-5. PubMed ID: 6705691
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of ursodeoxycholic acid on liver structure in man. Quantitative data.
    Koch MM; Giampieri MP; Lorenzini I; Jézéquel AM; Orlandi F
    Gastroenterol Clin Biol; 1980; 4(8-9):560-8. PubMed ID: 7429103
    [No Abstract]   [Full Text] [Related]  

  • 23. New therapeutic approach to overcome biliary sludge after liver transplantation.
    Müller GE; Bockhorn H; Fleischmann R; Müller GH
    Transplant Proc; 1981 Mar; 13(1 Pt 2):845-7. PubMed ID: 7022950
    [No Abstract]   [Full Text] [Related]  

  • 24. [Enzyme immunoassay of ursodeoxycholic acid (author's transl)].
    Setoguchi T
    Rinsho Byori; 1981 May; 29(5):443-5. PubMed ID: 7026843
    [No Abstract]   [Full Text] [Related]  

  • 25. [Further progress in the pharmacological dissolution of biliary calculi with ursodeoxycholic acid].
    Bojanowicz K; Witkowska A
    Wiad Lek; 1981 Aug; 34(16):1363-7. PubMed ID: 7340149
    [No Abstract]   [Full Text] [Related]  

  • 26. [Undesirable effects of chenodeoxycholic acid and ursodeoxycholic acid: what the goose and the bear don't have in common].
    Capron JP
    Gastroenterol Clin Biol; 1980; 4(8-9):526-30. PubMed ID: 7429098
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ursodeoxycholic acid as anti-dyspeptic in surgically treated lithiasis].
    Polo M; Mastria CA
    Minerva Dietol Gastroenterol; 1985; 31(4):661-4. PubMed ID: 4088515
    [No Abstract]   [Full Text] [Related]  

  • 28. Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid.
    Fromm H
    Gastroenterology; 1984 Jul; 87(1):229-33. PubMed ID: 6724267
    [No Abstract]   [Full Text] [Related]  

  • 29. Cholesterol absorption during bile acid feeding. Effect of ursodeoxycholic acid (UDCA) administration.
    Ponz de Leon M; Carulli N; Loria P; Iori R; Zironi F
    Gastroenterology; 1980 Feb; 78(2):214-9. PubMed ID: 7350042
    [No Abstract]   [Full Text] [Related]  

  • 30. Ursodeoxycholic acid and liver microsomal mixed function oxidase system in man.
    Di Padova C; Tritapepe R; Marabini L; Di Padova F; Rovagnati P; Mazzocchi M
    Methods Find Exp Clin Pharmacol; 1981; 3(4):209-11. PubMed ID: 7278432
    [No Abstract]   [Full Text] [Related]  

  • 31. Kinetics of cholesterol gallstone dissolution by glycocheno-, glyco-ursodeoxycholic acid, and mixtures of both in vitro.
    Raedsch R; Stiehl A; Götz R; Walker S; Kommerell B
    Z Gastroenterol; 1981 Apr; 19(4):159-63. PubMed ID: 7234028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of bile acids. VII. Metabolism of ursodeoxycholic acid in female rats.
    Ota M; Tsuji Y; Hoshita T
    Hiroshima J Med Sci; 1978 Jun; 27(2):139-45. PubMed ID: 711508
    [No Abstract]   [Full Text] [Related]  

  • 33. International symposium on ursodeoxycholic acid, Paris, 1980. Abstracts.
    Med Chir Dig; 1980; 9(7):619-35. PubMed ID: 7218921
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current treatment of gallbladder calculi].
    Mamianetti A
    Acta Gastroenterol Latinoam; 1984; 14(4):327-30. PubMed ID: 6537707
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ursodeoxycholic acid (UDCA) in the treatment of cholesterol cholelithiasis of the gallbladder and bile ducts].
    Goszcz A
    Pol Tyg Lek; 1983 Feb; 38(7):221-4. PubMed ID: 6346288
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ursodeoxycholic acid in the treatment of dyspeptic-painful disorders of biliary origin: report of a controlled multicenter study].
    Alvisi V; Tralli M; Loponte A; D'Ambrosi A; Pavani F; Ruina M
    Clin Ter; 1982 Jan; 100(1):21-33. PubMed ID: 6759007
    [No Abstract]   [Full Text] [Related]  

  • 37. [A clinical significance of oral ursodeoxycholic acid tolerance test for patients with hepatobiliary diseases by using radioimmunoassay (author's transl)].
    Shinozaki K
    Rinsho Byori; 1981 May; 29(5):475-7. PubMed ID: 7289113
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans.
    Salen G; Colalillo A; Verga D; Bagan E; Tint GS; Shefer S
    Gastroenterology; 1980 Jun; 78(6):1412-8. PubMed ID: 7372061
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
    Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
    [No Abstract]   [Full Text] [Related]  

  • 40. Noninvasive measurement of nutrient portal blood shunting.
    Hoefs J
    Hepatology; 1983; 3(3):464-5. PubMed ID: 6840692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.